Fund Holdings — Velan Capital Investment Management LP

Total Portfolio Value:
$92.12M
Total Bought:
$14.15M
Total Sold:
$88.96M
Net Transaction:
-$74.81M
Securities
▲▼
SharesValue
Q2 2024
▲▼
Q3 2024
▲▼
Change
▲▼
Q2 2024
▲▼
Q3 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Jasper Therapeutics, Inc.(JSPR)1,471,9041,433,828-38,076$32.55M$26.97M29.28%-$5.58M
Praxis Precision Medicines, Inc.(PRAX)350,666350,6660$14.50M$20.18M21.90%+$5.67M
Heron Therapeutics, Inc.(HRTX)6,986,7446,986,7440$24.45M$13.90M15.09%-$10.55M
Tourmaline Bio Inc319,080331,190+12,110$4.10M$8.51M9.24%+$4.41M
Rezolute, Inc.(RZLT)800,000800,0000$3.44M$3.88M4.21%+$440.0K
Liquidia Corporation(LQDA)0300,000+300,000$0$3.00M3.26%+$3.00M
Context Therapeutics Inc.(CNTX)1,290,3231,290,3230$2.59M$2.53M2.75%-$58.1K
InspireMD, Inc.(NSPR)904,029904,0290$2.26M$2.42M2.63%+$167.0K
Scpharmaceuticals Inc0517,668+517,668$0$2.36M2.56%+$2.36M
TELA Bio, Inc.(TELA)746,087747,410+1,323$3.51M$1.89M2.05%-$1.62M
Optinose Inc2,492,8302,146,608-346,222$2.59M$1.44M1.56%-$1.15M
Zevra Therapeutics, Inc.(ZVRA)0200,000+200,000$0$1.39M1.51%+$1.39M
Protara Therapeutics, Inc.(TARA)480,000574,000+94,000$998.4K$1.05M1.14%+$52.0K
Corbus Pharmaceuticals Holdings, Inc.(CRBP)050,000+50,000$0$1.03M1.12%+$1.03M
Skye Bioscience, Inc.(SKYE)422,142211,071-211,071$3.38M$825.3K0.90%-$2.56M
Kiora Pharmaceuticals, Inc.(KPRX)122,223122,2230$513.3K$447.3K0.49%-$66.0K
Tenax Therapeutics, Inc.(TENX)083,333+83,333$0$288.3K0.31%+$288.3K
Alimera Sciences Inc13,608,5330-13,608,533$75.66M$0—-$75.66M
Aslan Pharmaceuticals LtdADS625,0000-625,000$187.5K$0—-$187.5K
Elevation Oncology Inc597,2990-597,299$1.61M$0—-$1.61M
Outlook Therapeutics, Inc.(OTLK)247,0840-247,084$1.82M$0—-$1.82M
X4 Pharmaceuticals, Inc.(XFOR)659,0200-659,020$382.2K$0—-$382.2K
Page 1 of 1